Kisho

National Cancer Institute, Div of Cancer Treatment & Diagnosis (DCTD) — Rare Disease Pipeline | Kisho | Kisho

National Cancer Institute, Div of Cancer Treatment & Diagnosis (DCTD)

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
stage I endometrioid carcinoma	3-aminopyridine-2-carboxaldehyde thiosemicarbazone	Orphan Designation	-
stage II endometrioid carcinoma	3-aminopyridine-2-carboxaldehyde thiosemicarbazone	Orphan Designation	-
stage IVb bladder cancer	3-aminopyridine-2-carboxaldehyde thiosemicarbazone	Orphan Designation	-